Research programme: intra-neuronal antibody - CytoDel
Latest Information Update: 03 Feb 2021
At a glance
- Originator CytoDel; NYU Grossman School of Medicine
- Class Analgesics; Immunoglobulins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders; Pain
Most Recent Events
- 07 Jan 2021 CytoDel has patent protection for intra-neuronal antibody in USA (CytoDel website, January 2021)
- 07 Jan 2021 Early research in Neurological disorders in USA (Parenteral)
- 07 Jan 2021 Early research in Pain in USA (Parenteral)